2024-518348-19-00Not yet recruitingPhase 1
A phase I study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in patients with solid tumors
Source: EU CTIS (euclinicaltrials.eu) · Last updated 21 Oct 2026
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- First submitted
- 29 Jun 2026
- Start date
- 12 Oct 2026
- Lead sponsor
- Novartis Pharma AG
- Diseases
- Metastatic breast cancer, Triple-negative breast cancer, Bladder cancer, Gastric and esophageal cancer, Lung cancer
- EU CT number
- 2024-518348-19-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 64
- 11 sites in 6 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (11)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cliniques Universitaires Saint-Luc | Sint-Lambrechts-Woluwe | Belgium | Not yet recruiting |
| University Hospital Cologne AöR | Cologne | Germany | Not yet recruiting |
| Universitaetsklinikum Essen (AoR) | Essen | Germany | Not yet recruiting |
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | Not yet recruiting |
| Institut Catala D'oncologia | L'Hospitalet de Llobregat | Spain | Not yet recruiting |
| Hospital General Universitario Gregorio Marañón | Madrid | Spain | Not yet recruiting |
| Centre Leon Berard | Lyon | France | Not yet recruiting |
| Institut Paoli-Calmettes | Marseille | France | Not yet recruiting |
| Istituto Europeo di Oncologia s.r.l | Milan | Italy | Not yet recruiting |
| IRCCS Istituto Nazionale Tumori Fondazione Pascale | Naples | Italy | Not yet recruiting |
| Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E. | Porto | Portugal | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.